Revenue | Over $500 million See Exact Annual Revenue |
---|---|
Employees | 100 - 500Exact Company Size |
Primary Industry | 325411 Medicinal & Botanical Manufacturing |
Additional NAICS Codes | 325412 Pharmaceutical Preparation Manufacturing |
Address | 6701 Evenstad Drive Maple Grove, MN 55369 |
Upsher-Smith Laboratories | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
---|---|---|---|
2023 | Over $500 million Details in Premium Report | ||
2022 | |||
2021 | |||
2020 | |||
2019 |
1-Year Growth Rate: 3-Year Growth Rate (CAGR): |
Upsher-Smith Laboratories P&L | $ Millions |
---|---|
Revenue (Sales) | |
Cost of Goods Sold | |
Gross Profit | |
Operating Expenses | |
Advertising | |
Salaries and wages | |
Other Operating Expenses | |
Total Operating Expenses | |
Operating Income | |
EBITDA | |
EBIT (Earnings Before Interest and Taxes) | |
Net Profit | |
Trademark | Date |
---|---|
THROCYSLA Pharmaceutical preparations for the prevention and treatment of kidney stones, kidney disorders, and diseases of the kidney | 04/05/2022 |
TIACYSTLA Pharmaceutical preparations for the prevention and treatment of kidney stones, kidney disorders, and diseases of the kidney | 04/05/2022 |
TIOFLURNA Pharmaceutical preparations for the prevention and treatment of kidney stones, kidney disorders, and diseases of the kidney | 04/05/2022 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
XYMOGEN | Orlando, FL | 100 |
AVANTI NUTRITIONAL LABORATORIES | Miami Lakes, FL | 37 |
NUTRITION FORMULATORS | Miramar, FL | 36 |
RTPR | Cabot, AR | 33 |
INTEGRATED BOTANICS | Fort Worth, TX | 29 |
COSMAX NBT USA | Garland, TX | 29 |
CJB INDUSTRIES | Valdosta, GA | 28 |
ALTERNATIVE LABORATORIES | Naples, FL | 28 |
S&B PHARMA | Azusa, CA | 28 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
UPSHER-SMITH LABORATORIES | Maple Grove, MN | 100 |
VITALDYNE | Cokato, MN | 6 |
PHARMAGANICS | Waconia, MN | 3 |
BIO-CAT MICROBIALS | Shakopee, MN | 2 |
VIDEOGUIDANCE.COM | Minnetonka, MN | 2 |
PANBELA THERAPEUTICS | Waconia, MN | 2 |
Company | Revenue ($ MM) |
---|---|
|